Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Clinical trial NCT05255991 · COMPLETED
Trial details
- NCT number
- NCT05255991
- Sponsor
- United Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2025-06-30
- Enrollment
- 597
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.